In patients with LC, standard screening/surveillance based on ultrasound (US) and alpha-fetoprotein (AFP) is suboptimal, because it is lacking in sensitivity and specificity [4,8]. The gene discussed is AFP; the disease is laryngotracheoesophageal cleft.